JP6581194B2 - 眼用インプラント送達装置および方法 - Google Patents
眼用インプラント送達装置および方法 Download PDFInfo
- Publication number
- JP6581194B2 JP6581194B2 JP2017523187A JP2017523187A JP6581194B2 JP 6581194 B2 JP6581194 B2 JP 6581194B2 JP 2017523187 A JP2017523187 A JP 2017523187A JP 2017523187 A JP2017523187 A JP 2017523187A JP 6581194 B2 JP6581194 B2 JP 6581194B2
- Authority
- JP
- Japan
- Prior art keywords
- implant
- guide sleeve
- shell
- syringe
- central channel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007943 implant Substances 0.000 title claims description 305
- 238000000034 method Methods 0.000 title description 10
- 239000003814 drug Substances 0.000 claims description 47
- 229940079593 drug Drugs 0.000 claims description 22
- 230000014759 maintenance of location Effects 0.000 claims description 21
- 230000000717 retained effect Effects 0.000 claims description 3
- 230000007246 mechanism Effects 0.000 description 25
- 229940124597 therapeutic agent Drugs 0.000 description 23
- 239000012530 fluid Substances 0.000 description 9
- 238000007373 indentation Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000012377 drug delivery Methods 0.000 description 6
- 238000009472 formulation Methods 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 4
- 210000003811 finger Anatomy 0.000 description 3
- 229940071643 prefilled syringe Drugs 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- 241000233866 Fungi Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002090 nanochannel Substances 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0026—Ophthalmic product dispenser attachments to facilitate positioning near the eye
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical & Material Sciences (AREA)
- Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Prostheses (AREA)
Description
本出願は、2014年7月15日に出願された同時係属中の米国仮特許出願シリアル番号62/026682号の35USC§119(e)下での優先権を主張するものである。この仮特許出願の開示を、参照によりその全文を本明細書に組み入れる。
本明細書では、薬物などの材料で眼用インプラントを容易に、再現可能に、かつ安全に充填するとともに、そのインプラントを患者に、例えば患者の眼に、挿入するための方法、装置およびシステムが記載される。眼における装置の設置について具体的に参照されるが、本明細書に記載されたシステムは、眼以外の部位、例えば整形外科的、歯科的、管腔的および経皮的な部位において使用される、多くの装置にも使用することができる。本明細書に記載のシステムおよび方法は、再充填可能な拡散式装置(refillable diffusion based device)のような、多くの薬物送達装置に使用するのによく適しており、多孔質構造が交換中の流体の流れを阻止する長期放出用に構成された、多孔質薬物放出構造を有する拡散装置に非常によく適する可能性ある。
Claims (15)
- キャリア部材を含む、眼用インプラント取扱いシステムであって、
前記キャリア部材は、
シェルの近位端から遠位端に向かって、少なくとも部分的にシェルを通過して延びる、中央チャネルを有するシェル;
前記シェルの前記中央チャネルの少なくとも第1の領域内に脱着可能に取り付けられたガイドスリーブであって、前記シェルの近位端からアクセス可能な、中央チャネル中に入る近位ポートを画定する、前記ガイドスリーブ;および
前記ガイドスリーブの遠位端に隣接する、前記シェルの前記中央チャネルの少なくとも第2の領域内に脱着可能に取り付けられたインプラント保持具であって、インプラント保持具の遠位端に、インプラントを解放可能に固定するように適合された、一対の把持具を有する、前記インプラント保持具
を含む、前記システム。 - ガイドスリーブを介して、ポートを通り中央チャネル中に挿入されるように寸法および形状が決められた、充填注射器をさらに含み、
任意に、充填注射器が中央チャネルに挿入されるときに、ガイドスリーブが、同時に、シェルから外れるとともに前記充填注射器に取り付く、請求項1に記載のシステム。 - ガイドスリーブが、ガイドスリーブが中央チャネル内に位置するときに、少なくとも1つのガイドスリーブスロット中に突出する、シェルの対応するタブを受け入れるように寸法および形状が決められている、少なくとも1つのガイドスリーブスロットを有し、
任意に、ガイドスリーブスロットの縁が、ロックされた第1の状態にあるとき、シェルタブの遠位端に当接する、請求項1または2に記載のシステム。 - 充填注射器が、外面を有する針アセンブリを有し、
任意に、中央チャネル内に位置するガイドスリーブを通して充填注射器を挿入すると、針アセンブリの外面とシェルタブの内面とを接触させて、シェルタブに付勢して、ガイドスリーブスロットから離れて外向きに屈曲させて、ガイドスリーブスロットの縁がシェルタブの遠位端に当接しなくなる、ロック解除された第2の状態になる、請求項2または3に記載のシステム。 - ガイドスリーブの領域は、ガイドスリーブタブを形成する、U字形スロットを有し、
任意に、ガイドスリーブタブは、中央チャネル内に位置するガイドスリーブの長手方向軸に向かって内側に突出する自由端を有する、請求項1〜4のいずれか一項に記載のシステム。 - 充填注射器は、第1の外径を有する第1の部分と、第2の外径を有する第2の部分とを有するとともに、第1の部分は、第2の部分の遠位に配置され、第1の外径は、第2の外径よりも大きい、請求項2〜5のいずれか一項に記載のシステム。
- 充填注射器がガイドスリーブを通って遠位に前進すると、充填注射器の第1の部分をガイドスリーブタブの自由端に当接させて、前記ガイドスリーブタブを前記ガイドスリーブの長手方向軸から離れて外向きに付勢する、請求項6に記載のシステム。
- 充填注射器がガイドスリーブを通りさらに遠位に前進すると、自由端が長手方向軸に向かって内側に、かつ、第1の部分に対して近位にある小径の第2の部分に向かって屈曲して戻るように、前記ガイドスリーブタブの自由端に対して遠位の第1の部分を前進させる、請求項7に記載のシステム。
- ガイドスリーブタブの自由端が、ガイドスリーブを充填注射器にロックする第1部分の近位棚に当接する、請求項5〜8のいずれか一項に記載のシステム。
- インプラント保持具が、充填注射器の針アセンブリの少なくとも一部分を受容するように構成された内部を有する、請求項4〜9のいずれか一項に記載のシステム。
- インプラントがリザーバから眼の中に薬物を送達することができるように、少なくとも部分的に眼に挿入されるように寸法および形状が決められた、保留構造とリザーバとを含む眼用インプラントをさらに含み、インプラントを眼に挿入するために使用可能なハンドル部材をさらに含む、請求項1〜10のいずれか一項に記載のシステム。
- 一対の把持具が、インプラントの充填ポートがインプラント保持具の内部から利用可能になるように、実質的にインプラントの保留構造のまわりに延びる、請求項11に記載のシステム。
- 一対の把持具の第1の把持具が第1の突出部を有し、前記一対の把持具の第2の把持具が第2の突出部を有するとともに
前記第1および第2の突出部は、保留構造がインプラント保持具の内部に保持され、リザーバがインプラント保持具の遠位に延びるように、インプラントの保留構造の遠位のくぼみ内に受容されるように構成されている、請求項12に記載のシステム。 - 中央チャネルが、シェルの遠位端領域を通って延びる窓で終端し、一対の把持具が、窓内に眼用インプラントを固定する、請求項1〜13のいずれか一項に記載のシステム。
- 眼用インプラントは、該インプラントの近位端から遠位端まで、該インプラントの中心を通って延びる、長軸を有し、前記インプラントの長軸は、中央チャネルの長軸と同心である、請求項14に記載のシステム。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462024682P | 2014-07-15 | 2014-07-15 | |
US62/024,682 | 2014-07-15 | ||
PCT/US2015/040633 WO2016011191A1 (en) | 2014-07-15 | 2015-07-15 | Ocular implant delivery device and method |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2017521219A JP2017521219A (ja) | 2017-08-03 |
JP2017521219A5 JP2017521219A5 (ja) | 2018-08-23 |
JP6581194B2 true JP6581194B2 (ja) | 2019-09-25 |
Family
ID=55079028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017523187A Active JP6581194B2 (ja) | 2014-07-15 | 2015-07-15 | 眼用インプラント送達装置および方法 |
Country Status (15)
Country | Link |
---|---|
US (3) | US10258503B2 (ja) |
EP (2) | EP3679908B1 (ja) |
JP (1) | JP6581194B2 (ja) |
KR (1) | KR102416726B1 (ja) |
CN (1) | CN106687079B (ja) |
AU (1) | AU2015289625B2 (ja) |
BR (1) | BR112017000774B1 (ja) |
CA (1) | CA2955186C (ja) |
ES (1) | ES2803102T3 (ja) |
IL (1) | IL250079B (ja) |
MX (1) | MX2017000609A (ja) |
MY (1) | MY182497A (ja) |
RU (1) | RU2695563C2 (ja) |
WO (1) | WO2016011191A1 (ja) |
ZA (1) | ZA201700387B (ja) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2391419B1 (en) | 2009-01-29 | 2019-06-12 | ForSight Vision4, Inc. | Posterior segment drug delivery |
WO2013116061A1 (en) | 2012-02-03 | 2013-08-08 | Forsight Vision4, Inc. | Insertion and removal methods and apparatus for therapeutic devices |
CA2907681C (en) | 2013-03-28 | 2022-11-22 | Forsight Vision4, Inc. | Ophthalmic implant for delivering therapeutic substances |
WO2016011191A1 (en) * | 2014-07-15 | 2016-01-21 | Forsight Vision4, Inc. | Ocular implant delivery device and method |
JP2017522122A (ja) | 2014-07-24 | 2017-08-10 | シノプシス サージカル インコーポレイテッドSinopsys Surgical,Inc. | 副鼻腔アクセスインプラントデバイスおよび関連する製品ならびに方法 |
RU2017105844A (ru) | 2014-08-08 | 2018-09-11 | Форсайт Вижн4, Инк. | Стабильные и растворимые составы ингибиторов рецепторных тирозинкиназ и способы их получения |
KR20170106298A (ko) | 2014-11-10 | 2017-09-20 | 포사이트 비젼4, 인크. | 확장 가능한 약물 전달 장치 및 이용 방법 |
US11432959B2 (en) | 2015-11-20 | 2022-09-06 | Forsight Vision4, Inc. | Porous structures for extended release drug delivery devices |
AU2017246889B2 (en) | 2016-04-05 | 2021-12-16 | Forsight Vision4, Inc. | Implantable ocular drug delivery devices |
JP7408542B2 (ja) * | 2017-09-20 | 2024-01-05 | シノプシス サージカル インコーポレイテッド | 副鼻腔流体アクセス埋め込み器具、アセンブリ、キット、および方法 |
CA3082891A1 (en) | 2017-11-21 | 2019-05-31 | Forsight Vision4, Inc. | Fluid exchange apparatus for expandable port delivery system and methods of use |
EP3698758A1 (en) * | 2019-02-20 | 2020-08-26 | Leibniz-Institut für Polymerforschung Dresden e.V. | Device and assemblies for oriented transport, microscopic investigation and oriented ejection of a tissue graft or implant |
CN110507476B (zh) * | 2019-09-12 | 2021-10-26 | 格劳科斯公司 | 制造眼部植入物输送装置的方法 |
HRP20240604T1 (hr) * | 2020-02-27 | 2024-07-19 | Istar Medical Sa | Paket za držanje i izdavanje sklopa osovine za isporuku implantata |
US20220054311A1 (en) * | 2020-08-12 | 2022-02-24 | United States Government As Represented By The Department Of Veterans Affairs | Eye Drop Dispensing Apparatus |
US20220133532A1 (en) | 2020-11-04 | 2022-05-05 | Aerie Pharmaceuticals, Inc. | Medical implant |
CA3232769A1 (en) | 2021-09-20 | 2023-03-23 | Mott Corporation | Polymer coating for medical devices and method of manufacture thereof |
USD1037439S1 (en) | 2022-01-17 | 2024-07-30 | EyePoint Pharamaceuticals, Inc. | Ocular injector |
USD1033637S1 (en) | 2022-01-24 | 2024-07-02 | Forsight Vision4, Inc. | Fluid exchange device |
CN114848289A (zh) * | 2022-05-06 | 2022-08-05 | 海思盖德(苏州)生物医学科技有限公司 | 一种眼部植入物输送器 |
CN114983670A (zh) * | 2022-05-30 | 2022-09-02 | 海思盖德(苏州)生物医学科技有限公司 | 一种眼内植入物输送器 |
CN118512302B (zh) * | 2024-07-23 | 2024-10-01 | 苏州朗目医疗科技有限公司 | 一种眼用缓释药输送系统 |
Family Cites Families (366)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2585815A (en) | 1947-01-16 | 1952-02-12 | Mclintock Duncan Menzies | Injection syringe |
US2564977A (en) | 1949-01-19 | 1951-08-21 | Hu Quang Hsi | Medical injecting apparatus |
US3232117A (en) | 1962-09-14 | 1966-02-01 | Roger Gilmont Instr Inc | Micrometer buret |
US3416530A (en) | 1966-03-02 | 1968-12-17 | Richard A. Ness | Eyeball medication dispensing tablet |
US3618604A (en) | 1969-06-09 | 1971-11-09 | Alza Corp | Ocular insert |
US3641237A (en) | 1970-09-30 | 1972-02-08 | Nat Patent Dev Corp | Zero order release constant elution rate drug dosage |
US4034756A (en) | 1971-01-13 | 1977-07-12 | Alza Corporation | Osmotically driven fluid dispenser |
US3995635A (en) | 1971-09-09 | 1976-12-07 | Alza Corporation | Ocular insert |
US3828777A (en) | 1971-11-08 | 1974-08-13 | Alza Corp | Microporous ocular device |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US3902495A (en) | 1974-01-28 | 1975-09-02 | Cavitron Corp | Flow control system |
US3961628A (en) | 1974-04-10 | 1976-06-08 | Alza Corporation | Ocular drug dispensing system |
US3949748A (en) | 1974-09-26 | 1976-04-13 | Oscar Malmin | Injection syringe having aspirating and metering capabilities |
US3949750A (en) | 1974-10-07 | 1976-04-13 | Freeman Jerre M | Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same |
US4093708A (en) | 1974-12-23 | 1978-06-06 | Alza Corporation | Osmotic releasing device having a plurality of release rate patterns |
US4014335A (en) | 1975-04-21 | 1977-03-29 | Alza Corporation | Ocular drug delivery device |
US4034758A (en) | 1975-09-08 | 1977-07-12 | Alza Corporation | Osmotic therapeutic system for administering medicament |
US3977404A (en) | 1975-09-08 | 1976-08-31 | Alza Corporation | Osmotic device having microporous reservoir |
US4014333A (en) | 1975-09-22 | 1977-03-29 | Mcintyre David J | Instrument for aspirating and irrigating during ophthalmic surgery |
US4077407A (en) | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
US4014334A (en) | 1976-02-02 | 1977-03-29 | Alza Corporation | Laminated osmotic system for dispensing beneficial agent |
US4111201A (en) | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for delivering selected beneficial agents having varying degrees of solubility |
US4111203A (en) | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system with means for improving delivery kinetics of system |
US4160452A (en) | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
US4220152A (en) | 1978-05-08 | 1980-09-02 | Pfizer Inc. | Delivery system |
US4220153A (en) | 1978-05-08 | 1980-09-02 | Pfizer Inc. | Controlled release delivery system |
US4200098A (en) | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
US4298000A (en) | 1978-11-08 | 1981-11-03 | Minnesota Mining And Manufacturing Company | Fluid dispensing device |
US4300557A (en) | 1980-01-07 | 1981-11-17 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for treating intraocular malignancies |
US4309776A (en) | 1980-05-13 | 1982-01-12 | Ramon Berguer | Intravascular implantation device and method of using the same |
US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
US4327725A (en) | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4484922A (en) | 1981-06-25 | 1984-11-27 | Rosenwald Peter L | Occular device |
US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
US4475916A (en) | 1982-03-18 | 1984-10-09 | Merck & Co., Inc. | Osmotic drug delivery system |
US4519801A (en) | 1982-07-12 | 1985-05-28 | Alza Corporation | Osmotic device with wall comprising cellulose ether and permeability enhancer |
US4673405A (en) | 1983-03-04 | 1987-06-16 | Alza Corporation | Osmotic system with instant drug availability |
US4883459A (en) | 1983-07-29 | 1989-11-28 | Reynaldo Calderon | Retrograde perfusion |
US4627850A (en) | 1983-11-02 | 1986-12-09 | Alza Corporation | Osmotic capsule |
US4777049A (en) | 1983-12-01 | 1988-10-11 | Alza Corporation | Constant release system with pulsed release |
US4712550A (en) | 1985-04-08 | 1987-12-15 | Sinnett Kevin B | Retinal tack |
US4609374A (en) | 1985-04-22 | 1986-09-02 | Alza Corporation | Osmotic device comprising means for governing initial time of agent release therefrom |
US4693886A (en) | 1985-04-22 | 1987-09-15 | Alza Corporation | Osmotic device with inert core |
EP0201611A1 (de) | 1985-05-10 | 1986-11-20 | B. Braun-SSC AG | Zwei-Kanülen-Spritze |
EP0228185B1 (en) | 1985-11-27 | 1990-07-25 | Thomas C. White | Tissue-implantable fluid-dissipating device |
US4781675A (en) | 1985-11-27 | 1988-11-01 | White Thomas C | Infusion cannula |
US4959217A (en) | 1986-05-22 | 1990-09-25 | Syntex (U.S.A.) Inc. | Delayed/sustained release of macromolecules |
US5322691A (en) | 1986-10-02 | 1994-06-21 | Sohrab Darougar | Ocular insert with anchoring protrusions |
US4863457A (en) | 1986-11-24 | 1989-09-05 | Lee David A | Drug delivery device |
DE3751871D1 (de) | 1986-12-23 | 1996-09-19 | Liposome Co Inc | Guanidinaminoglycosid enthaltende Liposome |
US4865846A (en) | 1988-06-03 | 1989-09-12 | Kaufman Herbert E | Drug delivery system |
US5174999A (en) | 1988-12-13 | 1992-12-29 | Alza Corporation | Delivery system comprising fluid ingress and drug egress |
WO1990007575A1 (en) | 1988-12-30 | 1990-07-12 | Anderson David M | Stabilized microporous materials and hydrogel materials |
US5098443A (en) | 1989-03-23 | 1992-03-24 | University Of Miami | Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents |
US5164188A (en) | 1989-11-22 | 1992-11-17 | Visionex, Inc. | Biodegradable ocular implants |
US5324280A (en) | 1990-04-02 | 1994-06-28 | Alza Corporation | Osmotic dosage system for delivering a formulation comprising liquid carrier and drug |
US5128145A (en) | 1990-06-13 | 1992-07-07 | Alza Corporation | Dosage form for Parkinson's disease, spasticity and muscle spasms |
US5084021A (en) | 1990-11-02 | 1992-01-28 | Baldwin Brian E | Patient controlled infusion apparatus and method |
US5378475A (en) | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
AU650113B2 (en) | 1991-04-05 | 1994-06-09 | Eli Lilly And Company | Sustained release capsule and formulations |
US5334189A (en) | 1991-06-03 | 1994-08-02 | Wade Stephen E | Device for controlled diffusion of a chemical substance |
US5282829A (en) | 1991-08-15 | 1994-02-01 | United States Surgical Corporation | Hollow body implants |
FR2682090B1 (fr) | 1991-10-03 | 1993-12-31 | Holzstoff Holding Sa | Systeme-reservoir pour diffusion prolongee d'un principe actif. |
US5681572A (en) | 1991-10-18 | 1997-10-28 | Seare, Jr.; William J. | Porous material product and process |
US5178622A (en) | 1991-11-01 | 1993-01-12 | Lehner Ii Robert H | Instrument for implanting a soft intraocular lens |
US5178635A (en) | 1992-05-04 | 1993-01-12 | Allergan, Inc. | Method for determining amount of medication in an implantable device |
US6096756A (en) | 1992-09-21 | 2000-08-01 | Albert Einstein College Of Medicine Of Yeshiva University | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists |
US5336175A (en) | 1992-10-29 | 1994-08-09 | Mames Robert N | Method for the treatment of retinal detachments |
US5443505A (en) | 1993-11-15 | 1995-08-22 | Oculex Pharmaceuticals, Inc. | Biocompatible ocular implants |
CA2140053C (en) | 1994-02-09 | 2000-04-04 | Joel S. Rosenblatt | Collagen-based injectable drug delivery system and its use |
US5770076A (en) | 1994-03-07 | 1998-06-23 | The Regents Of The University Of California | Micromachined capsules having porous membranes and bulk supports |
US5985328A (en) | 1994-03-07 | 1999-11-16 | Regents Of The University Of California | Micromachined porous membranes with bulk support |
US5516522A (en) | 1994-03-14 | 1996-05-14 | Board Of Supervisors Of Louisiana State University | Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same |
US5466233A (en) | 1994-04-25 | 1995-11-14 | Escalon Ophthalmics, Inc. | Tack for intraocular drug delivery and method for inserting and removing same |
AUPM897594A0 (en) | 1994-10-25 | 1994-11-17 | Daratech Pty Ltd | Controlled release container |
DK0788351T3 (da) | 1994-11-10 | 2003-05-26 | Univ Kentucky Res Found | Implanterbar, genopfyldelig anordning til hastighedsreguleret lægemiddeladministration direkte til en indre del af kroppen |
US5725493A (en) | 1994-12-12 | 1998-03-10 | Avery; Robert Logan | Intravitreal medicine delivery |
US5554132A (en) | 1995-03-30 | 1996-09-10 | Abbott Laboratories | Hand grip for use with syringe |
JP3670291B2 (ja) | 1995-05-14 | 2005-07-13 | オプトノール リミティド | 眼内移植片、導入装置 |
IL113723A (en) | 1995-05-14 | 2002-11-10 | Optonol Ltd | Intraocular implant |
US5609629A (en) | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
US6685940B2 (en) | 1995-07-27 | 2004-02-03 | Genentech, Inc. | Protein formulation |
US5773019A (en) | 1995-09-27 | 1998-06-30 | The University Of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
US6641708B1 (en) | 1996-01-31 | 2003-11-04 | Board Of Regents, The University Of Texas System | Method and apparatus for fractionation using conventional dielectrophoresis and field flow fractionation |
GB2310149A (en) | 1996-02-15 | 1997-08-20 | Nomix Chipman Ltd | Spray gun |
US20090005864A1 (en) | 1996-03-18 | 2009-01-01 | Eggleston Harry C | Modular intraocular implant |
US5951512A (en) | 1996-05-28 | 1999-09-14 | Horizon Medical Products, Inc. | Infusion port with modified drug reservoir |
US5797898A (en) | 1996-07-02 | 1998-08-25 | Massachusetts Institute Of Technology | Microchip drug delivery devices |
US5928662A (en) | 1996-07-31 | 1999-07-27 | Phillips; Andrew F. | Ocular drug delivery device |
AU7533696A (en) | 1996-12-13 | 1998-06-18 | Ciba-Geigy Ag | New materials |
PT973499E (pt) | 1997-03-31 | 2003-12-31 | Alza Corp | Sistema de administracao difusor implantavel |
US7160687B1 (en) | 1997-05-29 | 2007-01-09 | Cellomics, Inc. | Miniaturized cell array methods and apparatus for cell-based screening |
US5902598A (en) | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
US6039712A (en) | 1997-11-04 | 2000-03-21 | Terence M. Fogarty | Implantable injection port |
US8313454B2 (en) * | 1997-11-20 | 2012-11-20 | Optonol Ltd. | Fluid drainage device, delivery device, and associated methods of use and manufacture |
US6196993B1 (en) | 1998-04-20 | 2001-03-06 | Eyelab Group, Llc | Ophthalmic insert and method for sustained release of medication to the eye |
FR2784296B1 (fr) | 1998-09-18 | 2001-01-05 | Imedex Biomateriaux | Dispositif pour la formulation et la delivrance d'un melange, notamment pour l'application chirurgicale de ce melange |
US7973068B2 (en) | 1998-10-20 | 2011-07-05 | Omeros Corporation | Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation |
DE19948783C2 (de) | 1999-02-18 | 2001-06-13 | Alcove Surfaces Gmbh | Implantat |
US7914442B1 (en) | 1999-03-01 | 2011-03-29 | Gazdzinski Robert F | Endoscopic smart probe and method |
US6395300B1 (en) | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
US6472162B1 (en) | 1999-06-04 | 2002-10-29 | Thermogenesis Corp. | Method for preparing thrombin for use in a biological glue |
DK1187617T3 (da) | 1999-06-18 | 2004-04-13 | Alcon Mfg Ltd | Fremgangsmåde til at vælge koncentrationen af et amfipatisk antihistaminlægemiddel ved at bestemme lægemidlets overfladeaktivitetsmåltal |
US6638263B1 (en) | 1999-10-12 | 2003-10-28 | Durect Corporation | Regulation of drug delivery through flow diversion |
US6416777B1 (en) | 1999-10-21 | 2002-07-09 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
CN1292721C (zh) | 1999-10-21 | 2007-01-03 | 爱尔康公司 | 药物释放装置 |
US6331313B1 (en) | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
US20030212383A1 (en) | 2001-01-05 | 2003-11-13 | Dana Cote | System and methods for reducing intraocular pressure |
NZ520099A (en) | 2000-01-12 | 2005-03-24 | Becton Dickinson Co | Systems and methods for reducing intraocular pressure |
US20050119737A1 (en) | 2000-01-12 | 2005-06-02 | Bene Eric A. | Ocular implant and methods for making and using same |
US7077848B1 (en) | 2000-03-11 | 2006-07-18 | John Hopkins University | Sutureless occular surgical methods and instruments for use in such methods |
EP1186439A4 (en) | 2000-03-13 | 2004-12-08 | Seiko Epson Corp | SURFACE TREATMENT METHOD, SURFACE TREATED ARTICLE AND SURFACE TREATMENT DEVICE |
US7141152B2 (en) | 2000-03-16 | 2006-11-28 | Le Febre David A | Analyte species separation system |
US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
US6478800B1 (en) | 2000-05-08 | 2002-11-12 | Depuy Acromed, Inc. | Medical installation tool |
CA2420038C (en) | 2000-08-30 | 2010-11-09 | John Hopkins University | Devices for intraocular drug delivery |
ATE380042T1 (de) | 2000-09-06 | 2007-12-15 | Alcon Inc | Beschichtungsmittel mit veränderbarer klebrigkeit für augenimplantate |
US6303290B1 (en) | 2000-09-13 | 2001-10-16 | The Trustees Of The University Of Pennsylvania | Encapsulation of biomaterials in porous glass-like matrices prepared via an aqueous colloidal sol-gel process |
CA2434156A1 (en) | 2000-12-29 | 2002-07-25 | Bausch & Lomb Incorporated | Sustained release drug delivery devices |
CA2432225C (en) | 2001-01-03 | 2008-01-15 | Michael J. Brubaker | Sustained release drug delivery devices with prefabricated permeable plugs |
EP1404295B1 (en) | 2001-01-03 | 2007-10-10 | Bausch & Lomb Incorporated | Sustained release drug delivery devices with coated drug cores |
DE60137542D1 (de) | 2001-01-03 | 2009-03-12 | Bausch & Lomb | Wirkstoffabgabevorrichtungen mit verzögerter freisetzung mehrere stoffe enthaltend |
CA2432438C (en) | 2001-01-09 | 2011-04-26 | Microchips, Inc. | Flexible microchip devices for ophthalmic and other applications |
CA2433528A1 (en) | 2001-01-26 | 2002-08-01 | Bausch & Lomb Incorporated | Improved process for the production of sustained release drug delivery devices |
US7181287B2 (en) | 2001-02-13 | 2007-02-20 | Second Sight Medical Products, Inc. | Implantable drug delivery device |
US6713081B2 (en) | 2001-03-15 | 2004-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Ocular therapeutic agent delivery devices and methods for making and using such devices |
US20020133168A1 (en) | 2001-03-16 | 2002-09-19 | Smedley Gregory T. | Applicator and methods for placing a trabecular shunt for glaucoma treatment |
EP2316394B1 (en) | 2001-06-12 | 2016-11-23 | The Johns Hopkins University | Reservoir device for intraocular drug delivery |
IL159715A0 (en) | 2001-07-10 | 2004-06-20 | Teva Pharma | Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery |
IL144446A0 (en) | 2001-07-19 | 2002-05-23 | Prochon Biotech Ltd | Plasma protein matrices and methods for their preparation |
CA2446741C (en) | 2001-07-23 | 2009-09-29 | Alcon, Inc. | Ophthalmic drug delivery device |
JP4261343B2 (ja) | 2001-07-23 | 2009-04-30 | アルコン,インコーポレイティド | 眼薬投与装置 |
US7749528B2 (en) | 2001-08-29 | 2010-07-06 | Ricardo Azevedo Pontes De Carvalho | Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues |
ES2393101T3 (es) | 2001-08-29 | 2012-12-18 | Ricardo A. P. De Carvalho | Sistema implantable y sellable para la administración unidireccional de agentes terapéuticos a tejidos diana |
US20030118649A1 (en) | 2001-10-04 | 2003-06-26 | Jinming Gao | Drug delivery devices and methods |
US8663687B2 (en) | 2001-10-12 | 2014-03-04 | Monosol Rx, Llc | Film compositions for delivery of actives |
US20030119177A1 (en) | 2001-11-15 | 2003-06-26 | Lewis Gruber | Sample chip |
GB2399753B (en) | 2002-01-18 | 2006-04-19 | Michael E Snyder | Method of making a sustained release ophthalmological device |
US8364229B2 (en) | 2003-07-25 | 2013-01-29 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
RU2322233C2 (ru) | 2002-03-11 | 2008-04-20 | Алькон, Инк. | Имплантируемая система для доставки лекарственных средств |
US7074426B2 (en) | 2002-03-27 | 2006-07-11 | Frank Kochinke | Methods and drug delivery systems for the treatment of orofacial diseases |
US7939094B2 (en) | 2002-06-19 | 2011-05-10 | Boston Scientific Scimed, Inc. | Multiphase polymeric drug release region |
ATE424187T1 (de) | 2002-07-15 | 2009-03-15 | Alcon Inc | Bioerodierbare folie zur abgabe eines ophthalmischen arzneimittels |
US8425549B2 (en) | 2002-07-23 | 2013-04-23 | Reverse Medical Corporation | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
US20040019325A1 (en) | 2002-07-29 | 2004-01-29 | Medrip Ltd. | Syringe Pump |
US7468065B2 (en) | 2002-09-18 | 2008-12-23 | Allergan, Inc. | Apparatus for delivery of ocular implants |
TWI282271B (en) | 2002-09-18 | 2007-06-11 | Allergan Inc | Apparatus for delivery of ocular implants |
WO2004028477A2 (en) | 2002-09-29 | 2004-04-08 | Surmodics, Inc. | Methods for treatment and/or prevention of retinal disease |
US7794437B2 (en) | 2003-01-24 | 2010-09-14 | Doheny Retina Institute | Reservoirs with subretinal cannula for subretinal drug delivery |
WO2004073551A2 (en) | 2003-02-18 | 2004-09-02 | Massachusetts Eye And Ear Infirmary | Transscleral drug delivery device and related methods |
US20060258000A1 (en) | 2003-02-26 | 2006-11-16 | Allen Jared W | Use of steady-state oxygen gradients to modulate animal cell functions |
US20050255144A1 (en) | 2003-04-09 | 2005-11-17 | Directcontact Llc | Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases |
US20050074497A1 (en) | 2003-04-09 | 2005-04-07 | Schultz Clyde L. | Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases |
EP1671624B1 (en) | 2003-05-02 | 2010-08-11 | SurModics, Inc. | Delivery device for a controlled drug release of an active agent into the posterior section of the eye |
JP4824549B2 (ja) | 2003-05-02 | 2011-11-30 | サーモディクス,インコーポレイティド | 制御放出型の生体活性物質デリバリー・デバイス |
US8403941B2 (en) | 2003-06-02 | 2013-03-26 | Abbott Medical Optics Inc. | Intraocular lens and cartridge packaging with lens-loading function |
EP1635876A4 (en) | 2003-06-13 | 2009-05-06 | Becton Dickinson Co | IMPROVED INTRADERMAL ADMINISTRATION OF BIOACTIVE AGENTS |
WO2004112653A2 (en) | 2003-06-18 | 2004-12-29 | D-Crown Ltd. | Devices and methods for delivering and forming single and multiple stenting structures in situ |
US20040260380A1 (en) | 2003-06-18 | 2004-12-23 | D-Crown Ltd | Devices for delivering multiple stenting structures in situ |
US20040260381A1 (en) | 2003-06-18 | 2004-12-23 | D-Crown Ltd | Devices and methods for forming stenting structures in situ |
US8367410B2 (en) | 2003-06-20 | 2013-02-05 | Massachusetts Institute Of Technology | Application of electrical stimulation for functional tissue engineering in vitro and in vivo |
EP1684669A4 (en) | 2003-07-10 | 2008-01-02 | Alcon Inc | DEVICE FOR RELEASING AN OPHTHALMIC MEDICINAL PRODUCT |
FI120333B (fi) | 2003-08-20 | 2009-09-30 | Bioretec Oy | Huokoinen lääketieteellinen väline ja menetelmä sen valmistamiseksi |
US7252673B2 (en) * | 2003-09-10 | 2007-08-07 | Warsaw Orthopedic, Inc. | Devices and methods for inserting spinal implants |
CA2539324A1 (en) | 2003-09-18 | 2005-03-31 | Macusight, Inc. | Transscleral delivery |
US20050181018A1 (en) | 2003-09-19 | 2005-08-18 | Peyman Gholam A. | Ocular drug delivery |
EP1675636A4 (en) | 2003-09-24 | 2009-12-23 | Medi Stream Pty Ltd | MEDICATION HOLDER |
AU2006225241B2 (en) | 2003-09-24 | 2008-07-17 | Tianda Pharmaceuticals (Australia) Pty Limited | Medication Holder |
WO2005033798A2 (en) | 2003-10-03 | 2005-04-14 | University Of Washington | Electrochemical micromanufacturing system and method |
US7211272B2 (en) | 2003-12-22 | 2007-05-01 | Bausch & Lomb Incorporated | Drug delivery device |
AU2005214040B2 (en) | 2004-02-12 | 2011-03-31 | Neo Vista, Inc. | Methods and apparatus for intraocular brachytherapy |
US7276050B2 (en) | 2004-03-02 | 2007-10-02 | Alan Franklin | Trans-scleral drug delivery method and apparatus |
WO2005091922A2 (en) | 2004-03-03 | 2005-10-06 | Becton, Dickinson And Company | Methods and devices for improving delivery of a substance to skin |
ES2349954T3 (es) * | 2004-04-22 | 2011-01-13 | Advanced Vision Science, Inc. | Dispositivo para la implantación de unas lentes intraoculares deformables. |
US20050244472A1 (en) | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Intraocular drug delivery systems containing excipients with reduced toxicity and related methods |
US20050244469A1 (en) | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Extended therapeutic effect ocular implant treatments |
US20060182783A1 (en) | 2004-04-30 | 2006-08-17 | Allergan, Inc. | Sustained release intraocular drug delivery systems |
US20070059336A1 (en) | 2004-04-30 | 2007-03-15 | Allergan, Inc. | Anti-angiogenic sustained release intraocular implants and related methods |
US8685435B2 (en) | 2004-04-30 | 2014-04-01 | Allergan, Inc. | Extended release biodegradable ocular implants |
US8591885B2 (en) | 2004-04-30 | 2013-11-26 | Allergan, Inc. | Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems |
WO2006014484A2 (en) | 2004-07-02 | 2006-02-09 | Surmodics, Inc. | Methods and devices for the treatment of ocular conditions |
US7117870B2 (en) | 2004-07-26 | 2006-10-10 | Clarity Corporation | Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same |
AU2005267734A1 (en) | 2004-08-06 | 2006-02-09 | Sopherion Therapeutics, Inc. | Anti-angiogenic peptides and methods of use thereof |
WO2006031358A2 (en) | 2004-08-13 | 2006-03-23 | Hyperbranch Medical Technology, Inc. | Dendritic polymers, crosslinked gels, and their uses as ophthalmic sealants and lenses |
WO2006023530A2 (en) | 2004-08-16 | 2006-03-02 | Massachusetts Institute Of Technology | Compositions and methods for enhancing structural and functional nervous system reorganization and recovery |
WO2006031388A2 (en) | 2004-08-20 | 2006-03-23 | Hyperbranch Medical Technology, Inc. | Dentritic polymers, crosslinked gels, and their uses in orthopedic applications |
US20060052754A1 (en) | 2004-09-04 | 2006-03-09 | Fields Douglas W | Thumb trigger syringe pole |
WO2006031532A2 (en) | 2004-09-10 | 2006-03-23 | Surmodics, Inc. | Methods, devices, and coatings for controlled active agent release |
EP2452670A1 (en) | 2004-10-01 | 2012-05-16 | Ramscor, Inc. | Conveniently implantable sustained release drug compositions |
US20080038316A1 (en) | 2004-10-01 | 2008-02-14 | Wong Vernon G | Conveniently implantable sustained release drug compositions |
US20080207502A1 (en) | 2004-10-14 | 2008-08-28 | Sopherion Therapeutics, Inc. | Anti-Angiogenic Peptides and Methods of Use Thereof |
JO3000B1 (ar) | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
US20060129215A1 (en) | 2004-12-09 | 2006-06-15 | Helmus Michael N | Medical devices having nanostructured regions for controlled tissue biocompatibility and drug delivery |
US20060154981A1 (en) | 2005-01-12 | 2006-07-13 | Alcon, Inc. | Method of reducing intraocular pressure and treating glaucoma |
WO2006082588A2 (en) | 2005-02-07 | 2006-08-10 | Pharmalight Inc. | Method and device for ophthalmic administration of active pharmaceutical ingredients |
US20060257450A1 (en) | 2005-03-21 | 2006-11-16 | Sreenivasu Mudumba | Drug delivery systems for treatment of diseases or conditions |
US20060233858A1 (en) | 2005-03-08 | 2006-10-19 | Allergan, Inc. | Systems and methods providing targeted intraocular drug delivery |
US20070077270A1 (en) | 2005-03-28 | 2007-04-05 | Clemson University | Delivery devices and methods for long-term, targeted delivery of therapeutic agents to the eye and ear |
JP4937997B2 (ja) | 2005-03-30 | 2012-05-23 | ニューレンズ・リミテッド | 調節型眼内レンズ(aiol)アセンブリおよびそのための個別の構成要素 |
EP1875560A4 (en) | 2005-04-05 | 2011-02-09 | Univ Ohio State | DIFFUSION DELIVERY SYSTEM AND METHODS OF MAKING |
US20100168535A1 (en) | 2006-04-12 | 2010-07-01 | Mark Ries Robinson | Methods and apparatuses related to blood analyte measurement system |
US20060258994A1 (en) | 2005-05-12 | 2006-11-16 | Avery Robert L | Implantable delivery device for administering pharmacological agents to an internal portion of a body |
EP1895957A1 (en) | 2005-05-18 | 2008-03-12 | SurModics, Inc. | Insertion instrument for non-linear medical devices |
US20070088414A1 (en) | 2005-05-25 | 2007-04-19 | Campbell Robert L | Particulate formulations for intradermal delivery of biologically active agents |
US20060276738A1 (en) | 2005-06-06 | 2006-12-07 | Becker Bruce B | Lacrimal drainage bypass device and method |
TW200716140A (en) | 2005-06-17 | 2007-05-01 | Dynamis Therapeutics Inc | Treatment of inflammatory conditions |
US7893040B2 (en) | 2005-07-22 | 2011-02-22 | Oculis Ehf | Cyclodextrin nanotechnology for ophthalmic drug delivery |
US8663673B2 (en) | 2005-07-29 | 2014-03-04 | Surmodics, Inc. | Devices, articles, coatings, and methods for controlled active agent release or hemocompatibility |
US20070060887A1 (en) * | 2005-08-22 | 2007-03-15 | Marsh David A | Ophthalmic injector |
US20070212397A1 (en) | 2005-09-15 | 2007-09-13 | Roth Daniel B | Pharmaceutical delivery device and method for providing ocular treatment |
WO2007035621A1 (en) | 2005-09-16 | 2007-03-29 | (Osi) Eyetech, Inc. | Ophthalmic syringe |
WO2007038453A2 (en) | 2005-09-26 | 2007-04-05 | Advanced Ocular Systems Limited | Use of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation |
US20080003219A1 (en) | 2005-09-26 | 2008-01-03 | Minu, L.L.C. | Delivery of an ocular agent |
US20080167600A1 (en) | 2005-09-26 | 2008-07-10 | Peyman Gholam A | Device for delivery of an agent to the eye and other sites |
US20070072933A1 (en) | 2005-09-26 | 2007-03-29 | Peyman Gholam A | Delivery of an ocular agent |
US20070071756A1 (en) | 2005-09-26 | 2007-03-29 | Peyman Gholam A | Delivery of an agent to ameliorate inflammation |
TW200732347A (en) | 2005-10-06 | 2007-09-01 | Trophogen Inc | VEGF analogs and methods of use |
US8168584B2 (en) | 2005-10-08 | 2012-05-01 | Potentia Pharmaceuticals, Inc. | Methods of treating age-related macular degeneration by compstatin and analogs thereof |
US20090043253A1 (en) | 2005-10-11 | 2009-02-12 | Blake Podaima | Smart medical compliance method and system |
BRPI0617414A2 (pt) | 2005-10-14 | 2011-07-26 | Alcon Inc | mÉtodo para tratamento de formas primÁrias e secundÁrias de glaucoma |
US20080125406A1 (en) | 2005-10-14 | 2008-05-29 | Robin Alan L | Method for Treating Primary and Secondary Forms of Glaucoma |
JP4721425B2 (ja) | 2005-12-01 | 2011-07-13 | キヤノン株式会社 | 流体移動方法および流体移動装置 |
CN101336315B (zh) | 2005-12-07 | 2012-12-19 | 特拉维夫大学拉莫特有限公司 | 药物递送复合结构 |
US20070131611A1 (en) | 2005-12-13 | 2007-06-14 | General Electric Company | Membrane-based article and associated method |
US20070131610A1 (en) | 2005-12-13 | 2007-06-14 | General Electric Company | Membrane-based apparatus and associated method |
ES2762239T3 (es) | 2006-01-17 | 2020-05-22 | Alcon Inc | Dispositivo de tratamiento del glaucoma |
EP3338743A1 (en) | 2006-01-17 | 2018-06-27 | Novartis Ag | Drug delivery treatment device |
US20080216736A1 (en) | 2006-01-19 | 2008-09-11 | Takeda San Diego, Inc. | Microfluidic device with diffusion between adjacent lumens |
US8979770B2 (en) | 2006-02-24 | 2015-03-17 | Merck Sharp & Dohme Corp. | Extraction and diagnostic fluid devices, systems and methods of use |
US7625927B2 (en) | 2006-02-27 | 2009-12-01 | Alcon Research, Ltd. | Method of treating glaucoma |
US20100297046A1 (en) | 2006-03-31 | 2010-11-25 | Dynamis Therapeutics, Inc. | Compositions and Methods Related to Fructosamine-3-Kinase Inhibitors |
WO2007115259A2 (en) | 2006-03-31 | 2007-10-11 | Qlt Plug Delivery, Inc. | Nasolacrimal drainage system implants for drug therapy |
JP4889789B2 (ja) | 2006-04-18 | 2012-03-07 | チョンシャン ボータイ ファーマシューティック インストゥルメンツ カンパニーリミテッド | 無菌混合薬剤注射器 |
US8197435B2 (en) | 2006-05-02 | 2012-06-12 | Emory University | Methods and devices for drug delivery to ocular tissue using microneedle |
US7918814B2 (en) | 2006-05-02 | 2011-04-05 | Georgia Tech Research Corporation | Method for drug delivery to ocular tissue using microneedle |
US20080124372A1 (en) | 2006-06-06 | 2008-05-29 | Hossainy Syed F A | Morphology profiles for control of agent release rates from polymer matrices |
JP2009542710A (ja) | 2006-06-28 | 2009-12-03 | サーモディクス,インコーポレイティド | 活性剤送達用分解性及び非分解性マトリックスの併用 |
TW200815045A (en) | 2006-06-29 | 2008-04-01 | Jazz Pharmaceuticals Inc | Pharmaceutical compositions of ropinirole and methods of use thereof |
AU2007269259B2 (en) * | 2006-06-30 | 2012-05-31 | Aquesys Inc. | Methods, systems and apparatus for relieving pressure in an organ |
WO2008009120A2 (en) | 2006-07-19 | 2008-01-24 | Noab Biodiscoveries Inc. | Method and device to extract components contained in a fluid |
US20080152694A1 (en) | 2006-07-20 | 2008-06-26 | Neurosystec Corporation | Devices, Systems and Methods for Ophthalmic Drug Delivery |
WO2008016712A2 (en) | 2006-08-02 | 2008-02-07 | Inframat Corporation | Medical devices and methods of making and using |
US9039761B2 (en) * | 2006-08-04 | 2015-05-26 | Allergan, Inc. | Ocular implant delivery assemblies with distal caps |
JP2008054521A (ja) | 2006-08-29 | 2008-03-13 | Canon Inc | 細胞培養処理装置及び細胞培養処理方法 |
US8821943B2 (en) | 2006-09-12 | 2014-09-02 | Board Of Regents Of The University Of Nebraska | Methods and compositions for targeted delivery of therapeutic agents |
US20080066739A1 (en) | 2006-09-20 | 2008-03-20 | Lemahieu Edward | Methods and systems of delivering medication via inhalation |
JP5694664B2 (ja) | 2006-09-29 | 2015-04-01 | サーモディクス,インコーポレイティド | 生分解性眼用インプラント及び眼の病気を治療する方法 |
TW200817039A (en) | 2006-10-06 | 2008-04-16 | Dynamis Therapeutics Inc | Compositions and methods for skin lightening |
US9022970B2 (en) | 2006-10-16 | 2015-05-05 | Alcon Research, Ltd. | Ophthalmic injection device including dosage control device |
CA2667614A1 (en) | 2006-10-25 | 2008-09-25 | Revalesio Corporation | Method of wound care and treatment |
AU2007308840C1 (en) | 2006-10-25 | 2014-09-25 | Revalesio Corporation | Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution |
US8784898B2 (en) | 2006-10-25 | 2014-07-22 | Revalesio Corporation | Methods of wound care and treatment |
US8784897B2 (en) | 2006-10-25 | 2014-07-22 | Revalesio Corporation | Methods of therapeutic treatment of eyes |
US8609148B2 (en) | 2006-10-25 | 2013-12-17 | Revalesio Corporation | Methods of therapeutic treatment of eyes |
CA2668954C (en) | 2006-11-10 | 2020-09-08 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
US20080111282A1 (en) | 2006-11-10 | 2008-05-15 | Baojun Xie | Process for Making Three Dimensional Objects From Dispersions of Polymer Colloidal Particles |
US20100286791A1 (en) | 2006-11-21 | 2010-11-11 | Goldsmith David S | Integrated system for the ballistic and nonballistic infixion and retrieval of implants |
US20090263346A1 (en) | 2006-12-05 | 2009-10-22 | David Taft | Systems and methods for delivery of drugs |
EP2101745A4 (en) | 2006-12-05 | 2009-12-30 | Landec Corp | DISTRIBUTION OF MEDICINAL PRODUCTS |
US20080154241A1 (en) | 2006-12-07 | 2008-06-26 | Burkstrand Michael J | Latent stabilization of bioactive agents releasable from implantable medical articles |
US20080147021A1 (en) | 2006-12-15 | 2008-06-19 | Jani Dharmendra M | Drug delivery devices |
AR063619A1 (es) | 2006-12-18 | 2009-02-04 | Alcon Res Ltd | Dispositivos y metodos para la administraicion de un farmaco oftalmico |
EP2097044A4 (en) | 2006-12-26 | 2012-10-10 | Quadra Logic Tech Inc | DRUG RELIEF IMPLANTS FOR INHIBITING OPTICAL DEFECTS |
DK2124856T3 (en) | 2007-01-09 | 2019-02-11 | Fovea Pharmaceuticals | DEVICE FOR INTRAOCULAR INJECTION |
AU2008206953A1 (en) | 2007-01-19 | 2008-07-24 | Cinvention Ag | Porous, non-degradable implant made by powder molding |
UY30883A1 (es) | 2007-01-31 | 2008-05-31 | Alcon Res | Tapones punctales y metodos de liberacion de agentes terapeuticos |
US7905888B2 (en) | 2007-02-16 | 2011-03-15 | Brown David C | Apparatus for inserting flexible medical implant |
WO2008116165A2 (en) | 2007-03-21 | 2008-09-25 | Next Safety, Inc. | Methods and systems of delivering medication via inhalation |
US20080249501A1 (en) | 2007-04-09 | 2008-10-09 | Medtronic Vascular, Inc. | Methods for Simultaneous Injection and Aspiration of Fluids During a Medical Procedure |
US20080286338A1 (en) | 2007-05-15 | 2008-11-20 | Boston Foundation For Sight | Drug delivery system with scleral lens |
US8231892B2 (en) | 2007-05-24 | 2012-07-31 | Allergan, Inc. | Biodegradable drug delivery system |
US9365634B2 (en) | 2007-05-29 | 2016-06-14 | Angiochem Inc. | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
CA2688344C (en) | 2007-05-29 | 2019-09-03 | Angiochem, Inc. | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
US20090036827A1 (en) | 2007-07-31 | 2009-02-05 | Karl Cazzini | Juxtascleral Drug Delivery and Ocular Implant System |
US9808557B2 (en) | 2007-08-10 | 2017-11-07 | Trustees Of Tufts College | Tubular silk compositions and methods of use thereof |
US20090105749A1 (en) | 2007-09-07 | 2009-04-23 | Qlt Plug Delivery, Inc. - Qpdi | Insertion and extraction tools for lacrimal implants |
BRPI0817074A2 (pt) | 2007-09-07 | 2015-03-24 | Qlt Plug Delivery Inc | Aparelho, método para tratar uma desordem ocular, dispositivo de detecção e sistema de detecção |
NZ583678A (en) | 2007-09-07 | 2012-03-30 | Quadra Logic Tech Inc | Silicone matrix drug cores for sustained release of therapeutic agents |
US8308755B2 (en) | 2007-09-24 | 2012-11-13 | Ethicon Endo-Surgery, Inc. | Elliptical retractor |
US20090214601A1 (en) | 2007-09-28 | 2009-08-27 | Chappa Ralph A | Porous Drug Delivery Devices and Related Methods |
RU2475282C2 (ru) | 2007-10-05 | 2013-02-20 | Тико Хелскеа Груп Лп | Герметизирующий фиксатор для использования при хирургических операциях |
US20100310665A1 (en) | 2007-10-25 | 2010-12-09 | Revalesio Corporation | Bacteriostatic or bacteriocidal compositions and methods |
US20090227018A1 (en) | 2007-10-25 | 2009-09-10 | Revalesio Corporation | Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction |
WO2009055620A1 (en) | 2007-10-25 | 2009-04-30 | Revalesio Corporation | Bacteriostatic or bacteriocidal compositions and methods |
US20090263495A1 (en) | 2007-10-25 | 2009-10-22 | Revalesio Corporation | Bacteriostatic or bacteriocidal compositions and methods |
US20100303918A1 (en) | 2007-10-25 | 2010-12-02 | Revalesio Corporation | Compositions and methods for treating asthma and other lung disorders |
US20100009008A1 (en) | 2007-10-25 | 2010-01-14 | Revalesio Corporation | Bacteriostatic or bacteriocidal compositions and methods |
US9523090B2 (en) | 2007-10-25 | 2016-12-20 | Revalesio Corporation | Compositions and methods for treating inflammation |
WO2010062628A1 (en) | 2008-10-27 | 2010-06-03 | Revalesio Corporation | Compositions and methods for treating asthma and other lung disorders |
US10125359B2 (en) | 2007-10-25 | 2018-11-13 | Revalesio Corporation | Compositions and methods for treating inflammation |
US20100303917A1 (en) | 2007-10-25 | 2010-12-02 | Revalesio Corporation | Compositions and methods for treating cystic fibrosis |
US20100004189A1 (en) | 2007-10-25 | 2010-01-07 | Revalesio Corporation | Compositions and methods for treating cystic fibrosis |
US20100008997A1 (en) | 2007-10-25 | 2010-01-14 | Revalesio Corporation | Compositions and methods for treating asthma and other lung disorders |
CA2703000C (en) | 2007-11-05 | 2013-08-06 | Bausch & Lomb Incorporated | Water-immiscible materials as vehicles for drug delivery |
US8114883B2 (en) | 2007-12-04 | 2012-02-14 | Landec Corporation | Polymer formulations for delivery of bioactive materials |
EP2666510B1 (en) | 2007-12-20 | 2017-10-18 | University Of Southern California | Apparatus for controlled delivery of therapeutic agents |
US8414646B2 (en) | 2007-12-27 | 2013-04-09 | Forsight Labs, Llc | Intraocular, accommodating lens and methods of use |
US20100305514A1 (en) | 2008-01-10 | 2010-12-02 | Bausch & Lomb Incorporated | Intravitreal injection system having coaxial cannulae and use thereof |
WO2009094466A2 (en) | 2008-01-22 | 2009-07-30 | University Of Florida Research Foundation, Inc. | Contact lenses for extended release of bioactive agents containing diffusion attenuators |
US8201752B2 (en) | 2008-03-10 | 2012-06-19 | Vapore, Inc. | Low energy vaporization of liquids: apparatus and methods |
TNSN08110A1 (en) | 2008-03-11 | 2009-07-14 | Rekik Raouf Dr | Drug delivery to the anterior and posterior segment of the eye from drops |
WO2009117112A2 (en) | 2008-03-21 | 2009-09-24 | Novartis Ag | Powder dispersion apparatus, method of making and using the apparatus, components that can be used on the apparatus and other devices, and various active agents |
KR101771629B1 (ko) | 2008-03-31 | 2017-08-25 | 닛토덴코 가부시키가이샤 | 침투제 전달 시스템 및 그의 사용방법 |
DK2285439T3 (en) | 2008-04-04 | 2014-03-24 | Nektar Therapeutics | Aerosoliseringsanorning |
WO2009128932A1 (en) | 2008-04-15 | 2009-10-22 | Sarcode Corporation | Delivery of lfa-1 antagonists to the gastrointestinal system |
EP2280676A2 (en) * | 2008-04-25 | 2011-02-09 | The Regents of the University of California | Device to store and inject corneal graft |
US9132088B2 (en) | 2008-04-30 | 2015-09-15 | Mati Therapeutics Inc. | Composite lacrimal insert and related methods |
US8980325B2 (en) | 2008-05-01 | 2015-03-17 | Revalesio Corporation | Compositions and methods for treating digestive disorders |
US7846124B2 (en) | 2008-05-07 | 2010-12-07 | Becker Bruce B | Punctal anchor for lacrimal stent, introducer tool and method |
EP2320972B1 (en) | 2008-05-08 | 2020-07-01 | MiniPumps, LLC | Implantable drug-delivery devices |
CA2769307C (en) | 2008-07-11 | 2017-12-12 | Intellicyt Corporation | Multi-sample particle analyzer system and method for high throughput screening |
AU2009274127A1 (en) | 2008-07-21 | 2010-01-28 | Arstasis, Inc. | Devices, methods, and kits for forming tracts in tissue |
US20100022943A1 (en) | 2008-07-25 | 2010-01-28 | Medtronic Vascular, Inc. | Hydrodynamic Thrombectomy Catheter |
US20100023033A1 (en) | 2008-07-25 | 2010-01-28 | Medtronic Vescular, Inc. | Hydrodynamic Thrombectomy Catheter |
WO2010021993A1 (en) | 2008-08-19 | 2010-02-25 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease |
US7678078B1 (en) | 2008-10-21 | 2010-03-16 | KMG Pharma LLC | Intravitreal injection device, system and method |
US8221353B2 (en) | 2008-10-21 | 2012-07-17 | KMG Pharma, Inc | Intravitreal injection device and system |
DE102008054431B3 (de) | 2008-12-09 | 2010-06-17 | Pari Pharma Gmbh | Aerosoltherapievorrichtung |
TW201026300A (en) | 2009-01-02 | 2010-07-16 | Alcon Res Ltd | In-situ refillable ophthalmic implant |
US8235932B2 (en) | 2009-01-09 | 2012-08-07 | Becker Bruce B | Side-by-side lacrimal intubation threader and method |
US8545554B2 (en) | 2009-01-16 | 2013-10-01 | Allergan, Inc. | Intraocular injector |
EP2391419B1 (en) | 2009-01-29 | 2019-06-12 | ForSight Vision4, Inc. | Posterior segment drug delivery |
US8623395B2 (en) | 2010-01-29 | 2014-01-07 | Forsight Vision4, Inc. | Implantable therapeutic device |
WO2010093945A2 (en) | 2009-02-13 | 2010-08-19 | Glaukos Corporation | Uveoscleral drug delivery implant and methods for implanting the same |
ES2728225T3 (es) | 2009-02-20 | 2019-10-23 | 2 Bbb Medicines B V | Sistema de administración de fármacos a base de glutatión |
US8287494B2 (en) | 2009-03-23 | 2012-10-16 | Colin Ma | Intravitreal injection devices and methods of injecting a substance into the vitreous chamber of the eye |
EP2424507A4 (en) | 2009-04-27 | 2012-10-24 | Revalesio Corp | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INSULIN AND DIABETES RESISTANCE |
WO2010125416A1 (en) | 2009-04-27 | 2010-11-04 | Raouf Rekik | Drug delivery to the anterior and posterior segments of the eye |
US8815292B2 (en) | 2009-04-27 | 2014-08-26 | Revalesio Corporation | Compositions and methods for treating insulin resistance and diabetes mellitus |
WO2010132835A1 (en) | 2009-05-15 | 2010-11-18 | Arstasis, Inc. | Devices, methods and kits for forming tracts in tissue |
CA3186189A1 (en) | 2009-05-18 | 2010-11-25 | Dose Medical Corporation | Drug eluting ocular implant |
CN102596097B (zh) | 2009-06-03 | 2015-05-20 | 弗赛特实验室有限责任公司 | 一种眼插入件 |
US9005649B2 (en) | 2009-07-14 | 2015-04-14 | Board Of Regents, The University Of Texas System | Methods for making controlled delivery devices having zero order kinetics |
US20110033933A1 (en) | 2009-07-15 | 2011-02-10 | Morteza Gharib | Method applying hemodynamic forcing and klf2 to initiate the growth and development of cardiac valves |
AU2010282282A1 (en) | 2009-08-14 | 2012-03-01 | Genentech, Inc. | Biological markers for monitoring patient response to VEGF antagonists |
WO2011028850A1 (en) | 2009-09-01 | 2011-03-10 | Northwestern University | Delivery of therapeutic agents using oligonucleotide-modified nanoparticles as carriers |
EP2480270A4 (en) | 2009-09-21 | 2015-07-08 | Harvard Apparatus Regenerative Technology Inc | METHODS AND APPARATUSES FOR INTRODUCING CELLS INTO A TISSUE SITE |
US20120245505A1 (en) * | 2009-12-16 | 2012-09-27 | Robinson Michael R | Intracameral devices for sustained delivery |
CA2785468A1 (en) | 2009-12-23 | 2011-06-30 | Psivida Us, Inc. | Sustained release delivery devices |
US8430853B2 (en) | 2010-02-05 | 2013-04-30 | Johnson & Johnson Vision Care, Inc. | Implantation instruments, system, and kit for punctal implants |
JP5511530B2 (ja) * | 2010-06-10 | 2014-06-04 | Hoya株式会社 | 眼内レンズ挿入装置 |
CN103209733B (zh) | 2010-08-05 | 2015-12-16 | 弗赛特影像4股份有限公司 | 用于药物输送的注入器装置和方法 |
ES2894940T3 (es) | 2010-08-05 | 2022-02-16 | Forsight Vision4 Inc | Aparato para tratar un ojo |
EP2600876B1 (en) | 2010-08-05 | 2015-04-29 | Forsight Vision4, Inc. | Combined drug delivery methods and apparatus |
WO2012019047A2 (en) | 2010-08-05 | 2012-02-09 | Forsight Vision4, Inc. | Subconjunctival implant for posterior segment drug delivery |
US20140033800A1 (en) | 2010-11-11 | 2014-02-06 | Forsight Vision4, Inc. | Methods and apparatus to determine diffusion properties of porous structures for drug delivery |
CA2818612C (en) | 2010-11-19 | 2020-12-29 | Forsight Vision4, Inc. | Therapeutic agent formulations for implanted devices |
EP4249059A3 (en) | 2011-06-28 | 2023-11-29 | ForSight Vision4, Inc. | An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye |
EP2739252A4 (en) | 2011-08-05 | 2015-08-12 | Forsight Vision4 Inc | SMALL MOLECULE ADMINISTRATION USING AN IMPLANTABLE THERAPEUTIC DEVICE |
FR2980102B1 (fr) * | 2011-09-16 | 2014-10-31 | Medicontur Orvostechnikai Korlatolt Felelossegu Tarsasag | Dispositif pour injecter une lentille intraoculaire dans un œil |
US9883968B2 (en) | 2011-09-16 | 2018-02-06 | Forsight Vision4, Inc. | Fluid exchange apparatus and methods |
SG11201402794YA (en) * | 2011-12-02 | 2014-11-27 | Bioceptive Inc | Methods and apparatus for inserting a device or pharmaceutical into a uterus |
WO2013116061A1 (en) | 2012-02-03 | 2013-08-08 | Forsight Vision4, Inc. | Insertion and removal methods and apparatus for therapeutic devices |
MX349226B (es) * | 2012-06-04 | 2017-07-19 | Alcon Pharmaceuticals Ltd | Insertador de lentes intraoculares. |
CA2905496A1 (en) | 2013-03-14 | 2014-09-25 | Forsight Vision4, Inc. | Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant |
CA2907681C (en) | 2013-03-28 | 2022-11-22 | Forsight Vision4, Inc. | Ophthalmic implant for delivering therapeutic substances |
CA2896106C (en) * | 2013-04-03 | 2021-05-04 | Novartis Ag | Automated intraocular lens injector device |
US9987163B2 (en) * | 2013-04-16 | 2018-06-05 | Novartis Ag | Device for dispensing intraocular substances |
US20160302965A1 (en) | 2013-12-06 | 2016-10-20 | Forsight Vision4, Inc. | Implantable therapeutic devices |
WO2016011191A1 (en) | 2014-07-15 | 2016-01-21 | Forsight Vision4, Inc. | Ocular implant delivery device and method |
RU2017105844A (ru) | 2014-08-08 | 2018-09-11 | Форсайт Вижн4, Инк. | Стабильные и растворимые составы ингибиторов рецепторных тирозинкиназ и способы их получения |
KR20170106298A (ko) | 2014-11-10 | 2017-09-20 | 포사이트 비젼4, 인크. | 확장 가능한 약물 전달 장치 및 이용 방법 |
US11432959B2 (en) | 2015-11-20 | 2022-09-06 | Forsight Vision4, Inc. | Porous structures for extended release drug delivery devices |
AU2017246889B2 (en) | 2016-04-05 | 2021-12-16 | Forsight Vision4, Inc. | Implantable ocular drug delivery devices |
-
2015
- 2015-07-15 WO PCT/US2015/040633 patent/WO2016011191A1/en active Application Filing
- 2015-07-15 EP EP20161007.8A patent/EP3679908B1/en active Active
- 2015-07-15 BR BR112017000774-6A patent/BR112017000774B1/pt active IP Right Grant
- 2015-07-15 MY MYPI2017700148A patent/MY182497A/en unknown
- 2015-07-15 KR KR1020177003805A patent/KR102416726B1/ko active IP Right Grant
- 2015-07-15 RU RU2017104650A patent/RU2695563C2/ru active
- 2015-07-15 AU AU2015289625A patent/AU2015289625B2/en active Active
- 2015-07-15 MX MX2017000609A patent/MX2017000609A/es unknown
- 2015-07-15 CA CA2955186A patent/CA2955186C/en active Active
- 2015-07-15 CN CN201580048475.0A patent/CN106687079B/zh active Active
- 2015-07-15 US US15/325,995 patent/US10258503B2/en active Active
- 2015-07-15 ES ES15821698T patent/ES2803102T3/es active Active
- 2015-07-15 EP EP15821698.6A patent/EP3169289B1/en active Active
- 2015-07-15 JP JP2017523187A patent/JP6581194B2/ja active Active
-
2017
- 2017-01-12 IL IL250079A patent/IL250079B/en unknown
- 2017-01-17 ZA ZA2017/00387A patent/ZA201700387B/en unknown
-
2019
- 2019-04-10 US US16/380,786 patent/US11337853B2/en active Active
-
2022
- 2022-05-16 US US17/745,007 patent/US20220378609A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2955186C (en) | 2023-08-29 |
EP3169289B1 (en) | 2020-04-15 |
US20190350754A1 (en) | 2019-11-21 |
BR112017000774A2 (pt) | 2017-11-28 |
EP3169289A1 (en) | 2017-05-24 |
IL250079B (en) | 2021-08-31 |
WO2016011191A1 (en) | 2016-01-21 |
ES2803102T3 (es) | 2021-01-22 |
US11337853B2 (en) | 2022-05-24 |
MX2017000609A (es) | 2017-04-27 |
AU2015289625B2 (en) | 2019-10-10 |
EP3679908B1 (en) | 2024-09-04 |
EP3169289A4 (en) | 2018-03-07 |
RU2695563C2 (ru) | 2019-07-24 |
CN106687079B (zh) | 2019-10-11 |
JP2017521219A (ja) | 2017-08-03 |
NZ728374A (en) | 2021-02-26 |
BR112017000774B1 (pt) | 2021-12-14 |
CN106687079A (zh) | 2017-05-17 |
AU2015289625A1 (en) | 2017-02-02 |
CA2955186A1 (en) | 2016-01-21 |
EP3679908A1 (en) | 2020-07-15 |
IL250079A0 (en) | 2017-03-30 |
RU2017104650A (ru) | 2018-08-15 |
MY182497A (en) | 2021-01-25 |
US20220378609A1 (en) | 2022-12-01 |
RU2017104650A3 (ja) | 2019-02-18 |
ZA201700387B (en) | 2019-12-18 |
US10258503B2 (en) | 2019-04-16 |
KR102416726B1 (ko) | 2022-07-05 |
KR20170034396A (ko) | 2017-03-28 |
US20170165108A1 (en) | 2017-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6581194B2 (ja) | 眼用インプラント送達装置および方法 | |
JP7338892B2 (ja) | 安全注射器のためのシステム及び方法 | |
DK2099384T3 (en) | IMPLEMENTATION DEVICE AND PROCEDURE FOR INTRODUCING A SUBCUTANT IMPORTANT ELEMENT IN A BODY | |
CN102869399B (zh) | 药物输送装置 | |
JP4864863B2 (ja) | 自動注射器 | |
US8870822B2 (en) | Insertion device for insertion heads and infusion sets | |
JP2022103348A (ja) | 注入セットおよび挿入器アセンブリ | |
US20020188258A1 (en) | Hand-piece for injection device with a retractable and rotating needle | |
CN106061529A (zh) | 自动注射装置 | |
JP7090084B2 (ja) | 安全ニードルデバイスの一体化された充填および注入のためのキャップ | |
CN112165964B (zh) | 用于输出至少一种物质的输出设备和方法 | |
JP2020527083A (ja) | 労力を低減して医療容器内に含まれた組成物を注射するための支援型注射デバイス | |
US10420887B2 (en) | Syringe injection aid | |
US9694135B2 (en) | Revolving multi-cartridge hypodermic syringe and method of use | |
WO2012128129A1 (ja) | 穿刺針、薬剤投与装置およびシリンジポンプ | |
NZ728374B2 (en) | Ocular implant delivery device and method | |
JP2006305312A (ja) | 針被覆要素用の係合制御部を備える注射装置用の取り付けモジュール | |
WO2013146011A1 (ja) | 液体投与具 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180710 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180710 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190411 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190419 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190710 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190814 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190829 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6581194 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |